AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04777175 — intervention group
Intervention type: DRUG
Intervention: immunity therapy
Description: The patient receives immunotherapy
Study NCT06591078 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: electropuncture
Description: The needle was retained for 30 minutes. During the retention period, the needle was lifted and twisted for 3 times with even small amplitude every 10 minutes, and the complement method was performed for 3 times. No manipulation before the needle, cotton ball press directly out of the needle.~④ Frequency, course and time: Start at the same time as immunotherapy, and complete 1-2 times of electroacupuncture treatment per week; Electroacupuncture was performed 4 times per 28 days. The number of electroacupuncture treatment cycles and the number of immunotherapy courses should be consistent.
Study NCT06472232 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chloroprocaine
Description: Selection of low concentration of chloroprocaine as local anesthetic for labor analgesia
Study NCT06472232 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Chloroprocaine
Description: Selection of low concentration of chloroprocaine as local anesthetic for labor analgesia
Study NCT05985252 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Virtual ileostomy
Description: Laparoscopic or robotic surgery with virtual ileostomy
Study NCT05985252 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Diverting ileostomy
Description: Laparoscopic or robotic surgery with diverting ileostomy
Study NCT06398756 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional rehabilitation
Description: 17 patients with cerebral palsy meeting the criteria will undergo conventional rehabilitation
Study NCT06398756 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aquatic therapy
Description: 17 patients with cerebral palsy meeting the criteria will undergo convertional rehabilitation and aquatic therapy
Study NCT05592717 — intervention group
Intervention type: DRUG
Intervention: Yutiq
Description: YUTIQ® 0.18 mg as an intravitreal injection in the designated study eye.
Study NCT05669911 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Teal Health Self-Collection Device Group
Description: Participants will use the Instructions for Use to perform self-collection of cervicovaginal cells using the Teal Health Self-Collection Device, and will fill out a usability survey and a satisfaction and needs survey. A Pap smear will be performed by a clinician before or after self-collection.
Study NCT06405724 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Description: 133mg LB 20mL thoracic paravertebral nerve block
Study NCT06405724 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Ropivacaine
Description: 0.5% ropivacaine 20mL thoracic paravertebral nerve block
Study NCT05887388 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Connect-Home Plus
Description: Connect-Home Plus will introduce organizational structure to support delivery of transitional care processes. New elements of structure include:electronic health record (EHR) template, Connect-Home Plus Toolkit, and Staff Training. After structural elements are added, SNF staff will use Connect-Home Plus care processes to deliver the 2-step transitional care intervention.In Step 1, SNF nurses,therapists, and social workers will develop a Transition Plan of Care and prepare the patient and caregiver to manage the illness and functional needs. In Step 2, a dementia caregiving specialist will call the patient's home three times within 30 days of discharge. Both intervention steps will focus on key care needs, such as 1) home safety; 2) care of symptoms of ADRD; 3) symptom management; 4) medication reconciliation; 5) function and activity; and 6) coordination of follow-up medical care.
Study NCT05612620 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: coulture
Description: Samples from the vagina, fornix and cervical canal will be taken by introducing a flocked nylon swab to the vagina via a speculum and circular swabbing for 5-10 seconds before using any antiseptics.
Study NCT06214065 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: fMRI
Description: fMRI will be performed pre- and post-rTMS
Study NCT06214065 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS
Description: TMS procedures are scheduled during study sessions 2-4 between the two MRI scans on those days. Because rTMS induces neural changes that last about 1 hour, rTMS will be applied immediately before the second MRI scan on each day. Prior to the TMS visits, target coordinates and orientation vectors will be generated from the MRI data and the e-field models and loaded into Localite along with the participant's reconstructed T1 image. During the visits, the participant's head will be co-registered to the T1 using fiducial points at the Nasion and Tragi. TMS pulses will be delivered, using the Localite software to target and track the optimal orientation calculated with e-field modeling.
Study NCT05028543 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Conventional TLH
Description: Procedure: conventional Total laparoscopic hysterectomy the uterine artery will be identified close to the isthmus then coagulated at this level, close to the uterus , using bipolar diathermy. The utero-vesical fold will be dissected and the bladder will be pushed down done.. The vasculature of the uterus will now secured and this will be evidenced by the pale color of the fundus.~Using either bipolar diathermy , the cornual pedicles on one side will be desiccated and cut. Also, both the uterosacral and cardinal ligaments will be coagulated and cut. So that, the opposite side pedicles can be taken care of.. The infundibulopelvic ligaments will be coagulatd and cut if it is necessary to remove both ovaries. A vaginal cuff was inserted into the vagina to identify the vault, which will then cut laparoscopically using a monopolar hook, where the specimen will be completely detached.
Study NCT05028543 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Clipping of utrine artery at its origin before bginning of TLH
Description: the uterine artery will be dissected using posteriorly and medially to the infundibulopelvic ligament, the ureter should be first identified. The surgeon may grab the obliterated umbilical artery at the anterior abdominal wall and retract it. The movement of the umbilical artery may be Seen at the ovarian fossa perpendicular to the ureter~The uterine vessels will be clipped at their origin from the hypogastric vessels using aclip applier which will be introduced through 10mm trocar. clipping of the artery will be performed through application of two 5 mm size metallic clips in continuity and complete the laparoscopic hysterectomy with the same steps of the conventional method.
Study NCT05345899 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Evaluation of vitamin C level in plasma
Description: A protocol-specific blood test wil assess the vitamin C level in plasma
Study NCT05345899 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Evaluation of quality of life
Description: Several questionnaire will be completed by patients to evaluate quality of life: Analog and visual scale (EVA) pain, Neuropathic pain (DN) 4 questionnaire, EVA fatigue, Short Form (SF) 12 questionnaire and Hospital Anxiety and Depression scale (HAD questionnaire)
Study NCT02658396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GO-203-2C
Study NCT02658396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Study NCT06048978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Commercial native starch without processing
Description: A food-grade commercial native starch without processing that has been rehydrated into a pudding for oral consumption.
Study NCT06048978 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified starch with extrusion processing
Description: A food-grade modified starch with extrusion processing that has been rehydrated into a pudding for oral consumption.
Study NCT06384014 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: retrograde and orthograde root canal filling
Description: Apical resection application after root canal filling
Study NCT05306535 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Occlusal reduction
Description: Occlusal reduction of the experimental single rooted tooth after root canal completion will be done to evaluation reduction in postoperative pain and sensitivity to percussion
Study NCT05288803 — intervention group
Intervention type: OTHER
Intervention: Clinical decision support tool (CDS tool)
Description: The investigators will integrate the CDS tool into clinical practice at each participating clinic after data collection for the Control cohort is complete. All physical therapists at the participating clinic locations will use the CDS tool to inform rehabilitation decision making for Veterans with total knee arthroplasty. The CDS tool will provide personalized information regarding each Veterans' recovery in addition to personalized visit utilization guidelines. Clinicians will use the CDS tool with Veterans at their initial postoperative visits and every 2weeks throughout their course of care thereafter.
Study NCT05793268 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nuc Discontinuation
Description: Eligible patients are randomly allocated with a 1:1 ratio to continue viral suppression or stop the treatment (entecavir or tenofovir). Patients will be followed up for 3 years. For patients who are assigned to the finite Nuc therapy, they should be monitored monthly for the initial 3 months and then every 3-6 months thereafter for relapse.
Study NCT05793268 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Entecavir or Tenofovir
Description: Continuation of either entecavir or tenofovir treatment for 3 years
Study NCT05844007 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Trauma-Informed Yoga
Description: Trauma-informed yoga intervention, delivered either in-person or remotely for 6 weeks, twice weekly for 45 minutes sessions
Study NCT01081106 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Low-Level Laser Therapy
Description: A LLLT device at 670 nm will be used for light application using lasers affixed in a rotating helmet apparatus. Treatment will be given twice weekly prior to commencing chemotherapy and will be administered once a week until one week after the last chemotherapy.~administration.
Study NCT06001957 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Whole exome sequencing
Description: Bioinformatic analysis of raw WES data and variants prioritization were performed as previously described.~Reads were aligned to the hg38 reference genome sequence and visualized by Integrative Genomic Viewer.
Study NCT05198440 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: non-invasive neuromodulation
Description: The modulations of the vection phenomenon will then be studied over two sessions of 1h30, separated by a minimum of 3 to a maximum of 15 days (the first session will be performed following the MRI). Each session will include: the installation of an EEG headset and the parameterization of the stimulation (30 min), then a phase of recording of the vection with neuromodulation (1h) according to 2 experimental conditions:~* Experiment 1: recording of vection at rest (20 min), then during and after neurostimulation by tES (20 min). Active and sham (placebo) stimulation will be tested separately during the two sessions (counterbalanced order).~* Experiment 2: recording of vection during neuromodulation by rTMS triggered in real time (1h). Triggering will be based on behavioral response (experiment 2a) or oscillatory activity detection (experiment 2b). Active and sham (placebo) stimulation will be tested in both sessions (randomized order).
Study NCT05198440 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: electroencephalography
Description: The modulations of the vection phenomenon will then be studied over two sessions of 1h30, separated by a minimum of 3 to a maximum of 15 days (the first session will be performed following the MRI). Each session will include: the installation of an EEG headset and the parameterization of the stimulation (30 min), then a phase of recording of the vection with neuromodulation (1h) according to 2 experimental conditions:~* Experiment 1: recording of vection at rest (20 min), then during and after neurostimulation by tES (20 min). Active and sham (placebo) stimulation will be tested separately during the two sessions (counterbalanced order).~* Experiment 2: recording of vection during neuromodulation by rTMS triggered in real time (1h). Triggering will be based on behavioral response (experiment 2a) or oscillatory activity detection (experiment 2b). Active and sham (placebo) stimulation will be tested in both sessions (randomized order).
Study NCT05198440 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: anatomical MRI
Description: The modulations of the vection phenomenon will then be studied over two sessions of 1h30, separated by a minimum of 3 to a maximum of 15 days (the first session will be performed following the MRI). Each session will include: the installation of an EEG headset and the parameterization of the stimulation (30 min), then a phase of recording of the vection with neuromodulation (1h) according to 2 experimental conditions:~* Experiment 1: recording of vection at rest (20 min), then during and after neurostimulation by tES (20 min). Active and sham (placebo) stimulation will be tested separately during the two sessions (counterbalanced order).~* Experiment 2: recording of vection during neuromodulation by rTMS triggered in real time (1h). Triggering will be based on behavioral response (experiment 2a) or oscillatory activity detection (experiment 2b). Active and sham (placebo) stimulation will be tested in both sessions (randomized order).
Study NCT05272501 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Calming Touch
Description: The calming treatment consists of deep pressure massage and gentle facilitation. The therapist works with the vertical axis, center, respiration, body boundaries and the feet.
Study NCT05733117 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D
Description: cholecalciferol
Study NCT05029778 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: L-arginine 3g + L-Citruline 2 g
Description: receive L-arginine 3g + l-Citruline 2 g PO, for 24 h, until birth.
Study NCT05029778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: receive placebo 3g PO, for 24 h, until birth.
Study NCT05965544 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain (preoperative)
Description: After the patients are in the supine position and aseptic conditions are provided in the preoperative period, the fascia on the iliacus muscle will be determined with the help of an 8-12 MHz linear probe and a block will be applied with the in-plane technique. During the block, 0.2% bupivacaine concentration 0.5 mL/kg is routinely used in patients.
Study NCT05965544 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine-fentanyl
Description: The patient will be placed in the lateral decubitus position with the fractured side up. After the spinal anesthesia method was provided with aseptic conditions, 10 mg 0.5% bupivacaine + 20 mcg Fentanyl injection will be applied using a 26 Gauge pencil point needle through the L3-L4 or L4-L5 intervertebral space
Study NCT05965544 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain (Postoperative)
Description: After the patients are in the supine position and aseptic conditions are provided in the postoperative period, the fascia on the iliacus muscle will be determined with the help of an 8-12 MHz linear probe and a block will be applied with the in-plane technique. During the block, 0.2% bupivacaine concentration 0.5 mL/kg is routinely used in patients.
Study NCT06628830 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VamosJuntxs App
Description: Psychoeducational materials (videos, information and interactive exercises) about depression, anxiety and social support~Skills training through information and activities based on the principles of cognitive behavioral therapy (cognitive restructuring, behavioral activation, emotional regulation, problem solving and exposure)
Study NCT06628830 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Web Conciencia Saludable
Description: mental health psychoeducational campaign (https://concienciasaludable.uchile.cl/)
Study NCT05641259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LP-108
Description: Oral administration for 21 or 28 days on a 28-day cycle
Study NCT05641259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Subcutaneous administration for 7 days on a 28-day cycle at the dose of 75mg/m2 2-2.5h hours after LP-108.
Study NCT05919173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride 0.25% Injection Solution
Description: Bupivacaine Hydrochloride 0.25% Injection Dose: 1mL/kg (milliliter per kilogram body weight)
Study NCT05919173 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bupivacaine Hydrochloride 0.25% Injection plus Dexmedetomidine 1 microgram/kg body weight
Description: Bupivacaine HCL 0.25% Injection plus Dexmedetomidine 1micro/kg Dose: 1 mL/kg (milliliter per kilogram body weight)
Study NCT05234697 — intervention group
Intervention type: DRUG
Intervention: Remifentanil
Description: Remifentanil was used for maintenance of anesthesia.
Study NCT05651061 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SS109
Description: 27 patients are enrolled in cohorts ,and will continue to be followed up until 28 days after SS109 administration for evaluating safety, PK/PD and immunogenicity.
Study NCT06204640 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Spironolactone
Description: Spironolactone will be start at 25 mg per day initially then titrated to a maximum of 50 mg per day in the absence of contraindication at the 1-month study visit.
Study NCT05945342 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Escitalopram
Description: The US Food and Drug Administration(FDA) has only approved fluoxetine and escitalopram for the treatment of adolescent depression
Study NCT05945342 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interpersonal Psychotherapy for Adolescent
Description: Interpersonal Psychotherapy for Adolescent(IPT-A), A modified version of interpersonal psychotherapy, is shorter than the standard therapy duration (12-16 sessions), with a total of eight sessions, retaining the structure of the standard IPT but employing a series of strategies to extract the most important components to speed up the time process.
Study NCT05945342 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Escitalopram combined with psychotherapy
Description: The subjects received adolescent interpersonal psychotherapy for adolescent(IPT-A) while taking medication
Study NCT05945342 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Escitalopram combined with rTMS
Description: The subjects received Robotic navigational repetitive transcranial magnetic stimulation while taking medication
Study NCT05945342 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Escitalopram combined with sham rTMS
Description: The subjects received sham Robotic navigational repetitive transcranial magnetic stimulation while taking medication
Study NCT05853991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: osteopathic manipulative treatment
Description: The intervention will be based on the specific assessment and treatment of the preterm developed by the team and validated through different studies.
Study NCT05853991 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator
Description: Application of affective touch
Study NCT05853991 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Application of static touch
Study NCT05336591 — intervention group
Intervention type: OTHER
Intervention: Covid-19 pandemic
Description: All participants worked during the Covid-19 pandemic in the preventive or curative healthcare for children with overweight and obesity. We will ask all professionals about their experiences during and after the pandemic.
Study NCT05938400 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Polyvinylsiloxane impression with different techniques
Description: One step impression technique will be compared with the standard two step technique
Study NCT05938400 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Polyvinylsiloxane impression with different techniques
Description: One step impression technique will be compared with the standard two step technique
Study NCT06001073 — intervention group
Intervention type: OTHER
Intervention: Observational; No Interventions were given.
Description: Observational; No Interventions were given.
Study NCT05251324 — intervention group
Intervention type: OTHER
Intervention: Hot Flush Induction
Description: A temperature-controlled, water-circulating heating pad at a constant temperature of 107˚F will be placed on the participant's torso, a microwaved heating neck pad will be placed on the participant's neck, and two warm balloons will be placed in the participant's hands for 30 min. Subjective (verbal start and end point to be marked on LabChart software) and objective (skin conductance and skin temperature) measures of hot flushes will be recorded.
Study NCT04799912 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Elective labor induction
Description: Elective labor induction at 39 weeks of gestation
Study NCT06317740 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: green management intervention program
Description: The program activities focused on integrating green management concepts into both theory and practice learning
Study NCT06317740 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: green management intervention program
Description: The program activities focused on integrating green management concepts into both theory and practice learning